TELL : +91 0 99 08 87 07 06

 Mcmed International ®: Largest Journal Publication in world

Acta Biomedica Scientia

Volume 6, Issue 3, 2019
Mcmed International
Acta Biomedica Scientia
Issn
2348 - 215X (Print), 2348 - 2168 (Online)
Frequency
bi-annual
Email
editorabs@mcmed.us
Journal Home page
http://mcmed.us/journal/abs
Recommend to
Purchase
Abstract
Title
ASSOCIATION OF SERUM FERRITIN AND HS-CRP LEVELS WITH METABOLIC SYNDROME.
Author
K. Narayanan, S. Raja, E.Prabhakar Reddy
Email
drpebyreddy@gmail.com
keyword
Metabolic Syndrome, Ferritin, Hscrp, Diabetes Mellitus, Cardiovascular Disorder
Abstract
Ferritin is one of the key proteins regulating iron homeostasis and is a widely available clinical biomarker of iron status. Some studies suggest that prevalence of atherosclerosis and insulin resistance increases significantly with increasing serum ferritin. Metabolic syndrome is known to be associated with increased risk of atherosclerosis as well as insulin resistance. The metabolic syndrome (MetS) also called syndrome X is a major and increasing public health and clinical challenge worldwide in the era of urbanization, because of increasing obesity and sedentary life habits. To measure the levels of hsCRP and ferritin in metabolic syndrome patients and age and sex matched controls and to compare the association of hsCRP and ferritin between the two groups and association with metabolic syndrome components. Serum ferritin and hsCRP levels with measured in 60 metabolic syndrome patients and60 controls and results were compared. From this study, we can conclude that the assessment of these novel risk factors [hs-CRP, Lp(a), and MetS] may be used for the risk estimation and can help to prevent future mortality and morbidity due to CVD
Back to Top >>>>